Kalaris Therapeutics, Inc. - KLRS
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q1 2026
· Q4 2025
Value (USD)
Total reported value ($000)
$109.6M
QoQ value delta ($000)
-$42.23M
(-27.81%)
Implied price effect (QoQ)
-31.16%
Shares
Total shares
18,871,561
QoQ shares delta
+875,392
(+4.86%)
Total shares held by funds (by quarter)
Market chart (KLRS)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q1 2026)
Top 25 only
Full list
Partial Q1 2026 data: 58 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.